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Parkinson’s disease is the second most common neurodegenerative disease. While age
is the most significant risk factor, the exact cause of this disease and the most effective
approaches to mitigation remain unclear. It has long been proposed that dopamine may
play a role in the pathology of Parkinson’s disease in view of its ability to generate
both protein-modifying quinones such as aminochrome and reactive oxygen species,
especially in the presence of pathological iron accumulation in the primary site of neuron
loss. Given the clinically measured acidosis of post-mortem Parkinson’s disease brain
tissue, the interaction between dopamine and iron was investigated over a pH range of
7.4 to 6.5 with emphasis on the accumulation of toxic quinones and generation of reactive
oxygen species. Our results show that the presence of iron accelerates the formation
of aminochrome with ferrous iron (Fe[II]) being more efficient in this regard than ferric
iron (Fe[III]). Our results further suggest that a reduced aminochrome rearrangement rate
coupled with an enhanced turnover rate of Fe[II] as a result of brain tissue acidosis could
result in aminochrome accumulation within cells. Additionally, under these conditions, the
enhanced redox cycling of iron in the presence of dopamine aggravates oxidative stress
as a result of the production of damaging reactive species, including hydroxyl radicals.
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INTRODUCTION
Parkinson’s disease is the second most common neurodegenerative disorder after Alzheimer’s
disease (Guttmacher et al., 2003). Even though the exact cause of Parkinson’s disease is still
unknown, two main pathological indicators are observed in the post-mortem brain; namely (i) loss
of dopamine-producing neurons in the substantia nigra pars compacta (SNc; Kordower et al., 2013)
and (ii) the widespread deposition of amyloid-like Lewy bodies rich in α-synuclein both in the SNc
and other brain regions where overt neurodegeneration is not observed (Surmeier et al., 2017).
Accumulation of iron (Fe) in the SNc is an additional pathological feature common to all forms
of Parkinson’s disease (Ayton and Lei, 2014) that appears to precede the onset of clinical symptoms
(Berg et al., 2015). Unlike synucleinopathy, brain Fe accumulation beyond that observed in normal
aging is an early-stage event (He et al., 2015) restricted to the degenerating nigrostriatal pathway
in Parkinson’s disease (Wang et al., 2016) with this association supporting a potential causative
role of Fe in neuron loss. In healthy neurons, Fe uptake is primarily via transferrin receptor
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mediated endocytosis, which releases labile Fe into the cytosol for
immediate distribution to various organelles and Fe-storage and
regulatory proteins. In dopaminergic neurons a small amount of
Fe is bound to neuromelanin, a biopolymer formed during the
oxidation of dopamine (DA). The labile iron pool is thought to
be transient and consists primarily of both ferrous (Fe[II]) and
ferric (Fe[III]) species bound to low molecular weight ligands
such as citrate and ATP (Double et al., 2002; Hare et al., 2013).
While characterization of the labile Fe pool in a living system,
particularly human tissue, remains an analytical challenge (New
et al., 2018), it has been argued that an increase in reactive
Fe in the labile iron pool may contribute to generation of
reactive oxygen species (ROS) in Parkinson’s disease at levels
above those that can normally be attenuated by endogenous
antioxidant mechanisms (Ward et al., 2014). Biochemically,
Fe-mediated generation of ROS is primarily via traditional
Fenton/Haber-Weiss chemistry (Equations 1, 2) where cytosolic
iron cycles between Fe[II] and Fe[III] to produce a range
of harmful oxidants, including superoxide (O•−2 ), hydrogen
peroxide (H2O2) and hydroxyl radicals (•OH; Graham et al.,
1978; Halliwell and Gutteridge, 1984; Segura-Aguilar et al., 2014;
Sun et al., 2016):
Fe[III]+O2
•− → Fe[II]+O2 (1)
Fe[II]+H2O2 → Fe[III]+
•OH+OH− (2)
The Fenton/Haber-Weiss reaction is not, however, unique to
dopaminergic neurons and normal Fe accumulation with age
occurs in other neuroanatomical regions (Acosta-Cabronero
et al., 2016) without causing generalized cell loss. Numerous
antioxidant mechanisms, including superoxide dismutase 1
(SOD1), reduced glutathione (GSH) and glutathione peroxidase,
and vitamin E-mediated scavenging of O•−2 , H2O2 and
•OH,
attenuate potential ROS-induced neurotoxicity from gradual
increase in Fe levels, suggesting that dysfunction of attenuating
mechanisms is involved in Fe-mediated dopaminergic cell death
in Parkinson’s disease (Zecca et al., 2004).
An emerging theory, supported by initial observations of
Fe dysregulation dating back nearly 100 years (Lhermitte
et al., 1924), suggests that abnormal interactions between Fe
and DA represent a biochemical mechanism unique to the
microchemical environment of vulnerable neurons (Hare et al.,
2014). Healthy dopaminergic neurons have particularly high
endogenous oxidative load, owing to their extensive and complex
axonal network, large soma and high metabolic output (Blesa
et al., 2015). Further, cytosolic DA present in the mid-µM range
in these neurons (Mosharov et al., 2009) gives rise to a pathway
Abbreviations: 6-OHDA, 6-hydroxydopamine; AFO, amorphous iron oxide;
DA, dopamine (1-amino-2-(3,4-dihydroxyphenyl)ethane); DA•−, semiquinone
radical; DAC, dopaminochrome; DAL, leukoaminochrome; DAQ, dopamine-o-
quinone; DHI, 5,6-dihydroxyindole; ECF, extracellular fluid; Fe[II], inorganic
ferrous ion; Fe[III], inorganic ferric ion; Fe[III]DA, mono-complex; Fe[III]DA2,
bis-complex; Fe[III]DA3, tris-complex; Fe[III]I , total inorganic Fe[III]; H2O2,
hydrogen peroxide; LMCT, ligand to metal charge transfer; MQ, Milli-Q water;
O•−2 , superoxide;
•OH, hydroxyl radical; ROS, reactive oxygen species; SNc,
substantia nigra pars compacta; TOR, turnover rate.
of Fe-mediated ROS generation independent of Fenton/Haber-
Weiss chemistry (Hare and Double, 2016). Dopamine-derived
quinones, such the DA o-quinone (DAQ) and aminochrome
(DAC) can also be produced via the Fe-driven generation of the
transient precursor DA semiquinone (DA•−) intermediary (Hare
and Double, 2016; Sun et al., 2018b). It is unclear if endogenous
antioxidant enzymes are capable of attenuating damage fromDA-
quinone production, though one proposed mechanism involves
polymerization as the dark pigment, neuromelanin (Zhang et al.,
2012).
As a major neurotoxic metabolite of DA, DAC has been used
as a preclinical model compound to examine neurotoxicity in
view of its apparent ability to cause indiscriminate neuronal
damage, including mitochondrial dysfunction (Herrera et al.,
2016; Segura-Aguilar and Huenchuguala, 2018), likely via lipid
peroxidation and disruption of membrane integrity. It has been
proposed that DAC can induce aggregation of α-synuclein
and eventual Lewy body deposition through formation of a
DAC-synuclein adduct (Berman and Hastings, 1999; Conway
et al., 2001; Bianco et al., 2002; Norris et al., 2005), and α-
synuclein mRNA has a predicted iron-response element in the
5′-untranslated region similar to the Fe-storage protein ferritin
(Friedlich et al., 2007), suggesting this hallmark protein of
Parkinson’s disease also plays a role in Fe-mediated toxicity
within vulnerable neurons. Previous studies also reported that
the presence of DA quinones may also aggravate oxidative stress
as a result of the inactivation in the electron transport chain of
mitochondrial complexes I and III and the subsequent leakage
of electrons from the respiratory chain (Stokes et al., 1999;
Adam-Vizi, 2005; Lin and Beal, 2006; Gautier et al., 2008).
Much of our understanding of Fe-mediated DA oxidation
has come from ex vivo studies where the chemical environment
remains relatively constant, or in vivo investigations using cell
culture or simple animal models of parkinsonism (Jiang et al.,
2013; Panicker et al., 2015; Sampson et al., 2016). While useful
and of most relevance, in vivo experiments generally provide
insight into the overall consequence of the whole process with
limited insights regarding the exact pathway, or pathways, of
DA transformation. As such, it is unlikely that location of the
most toxic intermediates or their relative concentrations will
be determined in such studies with resultant restrictions in
identifying the most efficacious therapeutic strategies targeting
toxic DAmetabolites. While previous work has firmly established
that aberrant reactions between Fe and DA give rise to increased
levels of free radicals and oxidative stress markers (Hermida-
Ameijeiras et al., 2004; Jiang et al., 2013), comparatively little
attention has been paid to the quantitative study of the DA
intermediates that are directly implicated in causing neuronal
dysfunction.Mitochondrial complex I inhibition byDA quinones
and subsequent mitochondrial dysfunction has been identified as
a possible molecular basis of neurodegeneration in Parkinson’s
disease (Schapira, 1994) and resulting intraneuronal acidosis
is likely to decrease cytoplasmic pH (Balut et al., 2008) and
influence the kinetics of Fe-mediated DA oxidation in vivo.
Further, while the frequently observed decrease in pH of post-
mortem brain tissue in the numerous tissue biobanks may result
from ex vivo handling (Hare et al., 2012), physiological effects of
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cardiorespiratory failure, cerebrovascular accident and end-stage
neurodegenerative diseases generally result in lower brain tissue
pH ranging from 7.0 to ∼ 6.0 (Hardy et al., 1985; Yates et al.,
1990; Harrison et al., 1995; Monoranu et al., 2009; Genoud et al.,
2017). Mitochondrial dysfunction, which is a cardinal feature of
neurodegenerative disease (Lin and Beal, 2006), also decreases
tissue pH via leakage of protons into the cytosol (Brand and
Nicholls, 2011). Thus, a reduction in brain tissue pH as a result of
disease progressionmay have a substantial role in accelerating the
progression of Fe-mediated DA oxidation in Parkinson’s disease.
To demonstrate the relevance of interplay between Fe and
DA to Parkinson’s disease under acidified conditions mimicking
predicted effects of disease-specific pre-mortem and non-specific
post-mortem changes, we examined interactions between DA and
Fe in vitro at a range of pH values–from pH 7.4, the typical pH of
extracellular fluid (ECF) to pH 6.5, which is the reported average
pH value of human Parkinson’s disease tissue from the Sydney
Brain Bank (Genoud et al., 2017) (though the specific location
within the brain from which these samples were drawn was not
reported). In the majority of previous studies, biochemical assays
were undertaken at pH 7.4 as opposed to intraneuronal values
that are typically around 6.96 to 7.05. This is a major limitation
given that the transformation and fate of a range of biochemical
compounds such as DA is strongly dependent upon pH. As Fe-
mediated DA oxidation is an aerobic process, we also examined
the effects of dissolved O2 concentration within aqueous systems
with respect to both the kinetics of Fe[II] oxidation and the
production of reactive DA intermediates. In order to facilitate
accurate and precise determination of reactive and unstable
quinone intermediates, these investigations of the influence of
pH and oxygen concentration on Fe-mediated DA oxidation have
been performed ex vivo. These fundamental studies are critical
for understanding Fe-DA reaction kinetics and set the stage for
future studies where the techniques described are applied to the
study of both the formation of neurotoxic DA metabolites in the
Parkinson’s disease brain and to the new therapies designed to
prevent abnormal reactions of Fe within dopaminergic neurons




All analytical grade chemicals were purchased from Sigma-
Aldrich (Castle Hill, Australia) or as otherwise stated. All
solutions were prepared using 18M·cm ultrapureMilli-Qwater
(MQ; Merck-Millipore, Bayswater, Australia). All glassware was
acid washed in 5% HCl (v/v) for at least 1 week, then thoroughly
rinsed in MQ before use. Stock solutions were stored in amber
glass bottles at 4◦C prior to use. To mimic the intracellular
environment and focus on the effect of pH on iron catalyzed
oxidation of DA, all experiments were performed in a light-free
environment at a controlled temperature of 22 ± 0.6◦C. This
temperature, rather than a physiological temperature of 37◦Cwas
selected to allow direct comparison with previous work at pH
7.4. Investigation of the effect of temperature on the processes
of interest in this work would be worthwhile though it should be
FIGURE 1 | Formation of H2O2 via the oxidation of 20µM DA in the absence
of added iron at pH 6.5, pH 7.0, and pH 7.4 in 0.1M NaCl solution. Error bars
are standard errors from triplicate measurements and solid lines represent the
model fit.
recognized that thermodynamic and kinetic data for many of the
key reactions underpinning these processes has been obtained by
other investigators in the temperature range 20–25◦C. Details of
the preparation of stock and working solutions can be found in
Supplementary Materials.
Preparation of Buffer Solutions
In general, despite often being considered “chemically
inert” (Yu et al., 1997; Thiel et al., 1998), buffers such
as 3-(N-morpholino)propanesulfonic acid (MOPS),
2-(N-morpholino)ethanesulfonic acid (MES) and 4-(2-
hydroxyethyl)piperazine-1-ethanesulfonic acid (HEPES)
may still exert an influence on the spectroscopic measurement
and/or formation of different target substances. As such, to
eliminate any buffer induced experimental artifacts, studies
were undertaken in 0.1M NaCl, 2mM NaHCO3 solutions
containing 10mM of MOPS, MES or HEPES by taking into
consideration their pH control range and the influence they may
exert on the measurement. Specifically, MOPS was used for the
measurement of the generation of Fe[III]DA2, DAC and H2O2
over pH 6.5–7.4 (Figures 1–4 and Supplementary Figure 5)
as it does not exhibit spectrum broadening effects. For the
measurement of Fe[II], MES was used at pH 6.5, while
HEPES was used at both pH 7.0 and 7.4 (Figure 4 and
Supplementary Figure 7) as a result of the pH control range of
these buffers and the negligible buffer facilitated reduction of
Fe[III] in the presence of ferrozine (FZ; 4-[3-pyridin-2-yl-5-(4-
sulfophenyl)-1,2,4-triazin-6-yl]benzenesulfonate) at pHs below
7.0.
Control of Dissolved O2 Content in Buffer Solutions
For experiments using variable O2 concentrations (0, 2.5, and 5%
dissolved O2), buffer solutions prepared above were sparged with
special gas mixtures (297 ± 6 ppm CO2 with or without 5% O2,
in Ar; BOC Gases, Preston, Australia) for at least 1 h before the
addition of DA and Fe (see Control of Dissolved O2 Content in
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FIGURE 2 | Formation of DAC in air-saturated (21% O2) 0.1M NaCl solutions
containing 20µM DA and 5µM iron (both Fe[III] and Fe[II]) at pH 7.0 (A), in
solutions containing 20µM DA and 5µM Fe[II] (B) and 5µM Fe[III] (C) at pH
6.5, pH 7.0, and pH 7.4. Error bars are standard errors from triplicate
measurements and solid lines represent the model fit.
Buffer Solutions). Constant O2 concentration was maintained by




All pH measurements were made using a Hanna Instruments
HI9025 pHmeter (Keysborough, Australia) with a glass electrode
and Ag-AgCl reference electrode. The pH meter and electrode
FIGURE 3 | Formation of H2O2 in air-saturated (21% O2) 0.1M NaCl
solutions containing 20µM DA and 5µM Fe[II] (A) and 5µM Fe[III] (B) at pH
6.5, pH 7.0, and pH 7.4. Error bars are standard errors from triplicate
measurements and solid lines represent the model fit.
were calibrated prior to each experiment using NIST-traceable
buffer solutions (pH 4.01, 7.01, and 10.01).
Ferrous Iron Quantification
Quantitative measurements of Fe[II] were made using the
modified FZ method as the reduction of DA bound iron occurs
in the presence of FZ at low pH (Garg et al., 2013). The UV
absorbance of Fe[II]FZ3 (both from inorganically and organically
bound Fe[II]) was monitored at 562 nm with baseline correction
at 690 nm. The concentration of total Fe[II] was then calculated
per the following (Garg et al., 2013):
[Fe[II]] =
(







where A562 is the recorded absorbance at 562 nm, εFe[II] and
εFe[III] are the molar absorption coefficients of the Fe[II]FZ
complex at 562 nm arising from the presence of Fe[II] and Fe[III],
respectively. [Fe]T is the total iron concentration, and l is the path
length (10 cm).
Iron-Dopamine Complex Measurements
The concentration of Fe[III]DA2 was determined
spectrophotometrically by measuring the absorbance at
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FIGURE 4 | Oxidation of 5µM Fe[II] at pH 6.5, pH 7.0, and pH 7.4 in air-saturated (21% O2) 0.1M NaCl solutions containing 10µM DA (A); oxidation of 5µM Fe[II] at
pH 7.0 in the presence of 2.5, 5, and 21% O2 (B); and the formation of Fe
IIIDA2 (C) in 0.1M NaCl solutions in the same O2 conditions. Formation of Fe
IIIDA2 in 0.1M
deoxygenated NaCl solutions containing 5µM Fe[III] and 50µM DA at pH 6.5, pH 7.0, and pH 7.4 (D). Error bars are standard errors from triplicate measurements
and solid lines represent the model fit. The experimental data at pH 7.4 was taken from Sun et al. (2016).
580 nm with baseline correction at 850 nm. Calibration curves
for quantification of the concentration of Fe[III]DA2 were
constructed from measurements performed under anoxic
conditions (Sun et al., 2016). Given the low concentrations and
weak absorptivity of the mono-complex, the effect of this species
on the measurement was considered negligible. It should be
noted, however, that the Fe[III]DA complex is a precursor to
the formation of the highly neurotoxic 6-OHDA quinone (Hare
and Double, 2016). The molar absorptivity of Fe[III]DA2 was
determined to be 3,121 M−1 cm−1 which was within 7% of
the previously published value (Sever and Wilker, 2004). As a
result of the slightly acidic pH and DA concentration used in
this study, the extent of formation of the tris-complex should be
negligible (Kowalchyk et al., 1995; Sun et al., 2018a). Even though
the spectrum of DAC can overlap with that of the Fe[III]DA2
complex at 580 nm, the influence of DAC was not considered
given the low concentration present (nominally <1µM) under
all conditions investigated herein (Pezzella et al., 1997) and
the small molar absorptivity of DAC at 580 nm (ε580 = 439
M−1cm−1).
Hydrogen Peroxide Measurements
The H2O2 formed from Fe-mediated DA oxidation was
quantified using the modified DPD method (Bader et al., 1988;
Voelker and Sulzberger, 1996; Sun et al., 2016). Briefly, 1mM
DTPA was added to quench H2O2 generation at each time point
in each assay (Sun et al., 2016). To eliminate interference from
subsequent H2O2 generation and/or consumption as a result of
the presence of high Fe[II] concentrations, 500µM BPY was
added prior to DTPA addition (Voelker and Sulzberger, 1996).
Quantitative data were interpolated by linear regression
analysis of absorbance at 551 nm by increasing concentrations
of H2O2 in 0.1M NaCl with 60µM DPD and 500 U/L HRP
added, including a standard blank. No apparent interferences
arising from the presence of moderate Fe[III] (5µM) and DA
(30µM) were identified (Supplementary Figure 1). In order to
enhance the accuracy of the measurements and remove potential
interference arising from DA residuals on H2O2 absorbance
measurements, the corresponding amount of DA, which was
exactly the same as that used in a specific experiment set,
was added to develop calibration curves for the experiments
containing high concentrations of Fe[II].
Aminochrome Quantification
The concentration of DAC was determined by measuring
absorbance at 475 nm with baseline correction at 850 nm
(Supplementary Figure 2; Herlinger et al., 1995; Pham and
Waite, 2014). Themolar absorptivity derived from the calibration
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curves indicated that the precursor DAQ was unlikely to
exert any influence on the measurement of DAC while most
phenolic organics, including DA (Supplementary Figure 3) and
5,6-dyhydroxyindole (DHI), only absorb at around 280 nm
(Il’ichev and Simon, 2003). As such, the influence arising from
the rearrangement products of DAC should be minimal at
475 nm. Absorbance at a particular wavelength is the sum
of the absorbances contributed from different species, thus
spectral overlap may cause false-positive measurements. Given
the coexistence of Fe[III]DA2 and DAC in solutions containing
iron and DA, the concentration of each species was determined















where A is the total absorbance at 475 nm, ε
j
i is the molar
absorptivity of species j at wavelength i, Cj is the concentration
of species j and l is the pathlength (10 cm). The concentration
of Fe[III]DA2 was initially quantified based on the absorbance at
580 nm as DAC absorbed negligibly at this wavelength.
Calibration curves of DACwere developed by adding different
concentrations of the freshly prepared DAC working solution
into the air-saturatedMOPS buffer solutions at pH 7.0 (Sun et al.,
2018a). The molar absorptivity of DAC calculated in this study
(ε475 nm = 3,245M−1cm−1) is similar to that reported by Segura-
Aguilar and Lind (1989) (ε475 = 3,085 M−1cm−1) and Pham and
Waite (2014) (ε475 = 3,281 M−1cm−1).
Speciation and Kinetic Modeling
The pH-dependent distributions of DA, Fe[III] and Fe[II]
species were determined using the program Visual Minteq
(Gustafsson, 2005). Details of the distributions are shown in
Supplementary Figure 4 with stability constants used in this
study provided in Supplementary Table 1.
The kinetic model developed to describe the experimental
data at pH 6.5, 7.0, and 7.4 was implemented using the software
Kintek Explorer (Johnson et al., 2009). Specifically, the kinetic
model is a set of reactions describing the key processes involved
in the interplay between Fe and DA. To apply the model
for the quantification of the time-dependent transformation of
reactants, intermediates and products, the rate constant for each
key process was either adopted from previous work or fitted in
this study. The “goodness of fit” was judged by the ability of the
reaction set used (and the associated set of coupled differential
equations representing the rate expressions for each reaction)
to describe the time-dependent transformation of a range of
substances. If the model provided a poor description of the data,
it indicated either a flaw in the reaction set or rate constant(s)
used. In addition to the data collected in the current work,
portions of the experimental data collected at pH 7.4 described by
Sun et al. (2016) were used to complement this dataset and fully
elucidate the effect of pH on DA oxidation. Given the critical role
of dissociation of DA bound Fe at lower pH and the improved
constraints provided by analysis of DAC, slight amendments
were applied to the kinetic model previously developed for pH
7.4 (Sun et al., 2016).
RESULTS
Development and Rationale of
Experimental Model
Given the relatively complicated model developed in this study,
several intermediates were measured in order to better constrain
the rate constants used herein. Briefly, (i) generation of DAC
and H2O2 (shown in Figures 1–3) are used to constrain the rate
constants for transformation of DA both in the absence and
presence of iron including those for the oxidation of DA and
leukoaminochrome (DAL) and cyclization of DAQ; (ii) decay
of Fe[II] and formation of Fe-DA complexes in the presence
of O2 (shown in Figures 4A–C) are used to constrain the
rate constant for the DA-induced transformation of Fe; and
(iii) formation of Fe[III]-DA complexes (shown in Figure 4D
and Supplementary Figure 5) in the absence of O2 is used to
constrain the rate constants for mono-complex formation, DA-
induced reductive dissolution of ferrihydrite (amorphous ferric
oxyhydroxide; or AFO) as well as the dynamic equilibrium
between the mono- and bis-complexes. Details of the various
reactions hypothesized to play a role are presented in Tables 1–3.
Sensitivity analysis was used to determine the relative importance
of the proposed reactions. Specifically, the greater the variation of
the relative residuals that occurred with the change in magnitude
of the rate constant, the more influential the reaction is. The
lowest point or the “shift point” shown in the sensitivity analysis
represents the optimal rate constant for the overall model
applied. To simplify the applied model, rate constants were
maintained consistent with those deduced in our previous study
(Sun et al., 2016) with the exception of those with significant
sensitivity to change of pH.
The sensitivity of the model to changes in individual rate
constant values, defined as the relative residual, r, was determined
using the programKintecus (Ianni, 2003) combined with a Visual
Basic for Applications (VBA) program. Note that the relative









where MPi is the model prediction, EDi is the experimental data
at the same condition and time interval and n represents the total
number of measured data points.
As shown in Supplementary Figures 6A,B, significant
influence of DAQ cyclization and DAC decay on the
transformation of DA was observed at the two pH values
investigated here (the results of previous studies at pH 7.4 are
provided by Sun et al., 2016). The most sensitive point of the
relative residual r increases in line with pH. This is in agreement
with the proposed rate constants (Tables 1–3) in the main text as
deprotonation is generally the prerequisite for DAQ cyclization
and DAC decay. In contrast, a relatively insensitive relative
residual r is observed below the deduced upper rate constant
(k5 = 5.3 × 106) for the redox exchange between DAQ and
DAL (Land et al., 2003; Sun et al., 2016), especially at pH 7.0
(Supplementary Figure 6C). As such, the rate constant of the
Frontiers in Neuroscience | www.frontiersin.org 6 November 2018 | Volume 12 | Article 859
Sun et al. pH, Iron, and Dopamine Oxidation
TABLE 1 | Modeled reactions and rate constants for the autoxidation of DA at pH 6.5, 7.0, and 7.4.
No. reactions Rate constants (M−1s−1 or s−1) References
pH 6.5 pH 7.0 pH 7.4
1 DA + O2
k1
−→ O•−2 + DA
•− k1 = 3.94 × 10
−3 k1 = 4.22 × 10
−3 k1 = 8.24 × 10
−3a This study




O•−2 + DAQ k2 = 2.95 × 10
3 1
k−2 = 1.0 × 10
9 1
3 DA•− + DA•−
k3




−→ DAL k4 = 1.23 × 10
−2 k4 = 1.0 k4 = 4.45
a This study
5 DAL + DAQ
k5
−→ DA + DAC k5 = 5.30 × 10
6 3
6 DAL + O2
k6
−→ DAC + H2O2 k6 = 1.17 k6 = 1.31 k6 = 5.12
a This study




−→ H2O2 + O2 k7 = 1.90 × 10
6 k7 = 6.0 × 10
5 k7 = 1.90 × 10
5 4
8 DA•− + O•−2
k8






Decay productsc k9 = 1.2 × 10
−6 k9 = 8 × 10
−5 k9 = 4 × 10
−4 This study
aValuemodified from that used in Sun et al. (2016). bRate constant taken from Sun et al. (2016). cThe rate constant proposed for reaction 9 incorporates the influence of Fe. DA, dopamine;
DA•−, semiquinone radical; DAQ, dopamine-o-quinone; DAC, aminochrome; DAL, leukoaminochrome; and O•−2 , superoxide. Refs: (1) Pham and Waite (2014); (2) Borovansky et al.
(2006); (3) Land et al. (2003); (4) Zafiriou (1990) and (5) Sun et al. (2016).
TABLE 2 | Modeled reactions and rate constants for Fe[III]-catalyzed oxidation of DA at pH 6.5,7.0 and 7.4.
No. reactions Rate constants (M−1s−1 or s−1) References
pH 6.5 pH 7.0 pH 7.4
10 Fe [III] + Fe [III ]
k10
−−→ AFO + nH+ k10 = 1.0 × 10
6 k10 = 3.4 × 10
6 k10 = 5.0 × 10
6 6
11 > Fe[III]n + DA
k11
−−→ > Fe[III]n – 1 + Fe
[III]DA k11 = 0.599 k11 = 2.3 k11 = 2.34
b This study
12 > Fe[III]n + DA
k12
−−→ > Fe[III]n – 1 + Fe[II] + DA
•− k12 = 0.008 k12 = 0.3 k12 = 0.6
b This study




Fe[III]DA k13 = 8.7 × 10
4 k13 = 2.09 × 10
5 k13 = 4.15 × 10
5a This study
k−13 = 1.45 k−13 = 0.969 k−13 = 0.463 This study




Fe[III]DA2 k14 = 4.50 × 10
5 7
k−14 = 3.37 × 10
−4 k−14 = 2.86 × 10
−4 k−14 = 2.59 × 10
−4 This study
15 Fe [III ] DA + O•−2
k15
−−→ Fe [ II ] DA + O2 k15 = 1.50 × 10
8 8
16 Fe [III ] DA
k16
−−→ Fe [II ] + DA•− k16 = 0.23 9
17 Fe [III ] DA2
k17
−−→ Fe [II ] + DA + DA•− k17 = 7.26 × 10
−5b 5
18 Fe [III ] + O•−2
k18
−−→ Fe [II ] + O2 k18 = 1.50 × 10
8 10




−−→ > Fe[III]n - 1 + Fe[II] + O2 k19 = 4.84 × 10
4 k19 = 3.70 × 10
5 k19 = 3.70 × 10
5b This study
20 Fe [III ] + DA•−
k20
−−→ Fe [II ] + DAQ k20 = 9.12 × 10
9 This study
aModified value of the model developed at pH 7.4 in Sun et al. (2016). bRate constant taken from Sun et al. (2016). DA, dopamine; DA•−, dopamine semiquinone radical; DAQ,
dopamine-o-quinone; O•−2 , superoxide; Fe[III], inorganic ferric ion; Fe[III]I, total inorganic Fe[III]; AFO, ferrihydrite; and Fe[II], inorganic ferrous ion. Refs: (6) Pham et al. (2006); (7) Blesa
and Matijevi (1989); (8) Rose and Waite (2003); (9) El-Avaan et al. (1997) and (10) Rush and Bielski (1985).
redox exchange reaction at both pH 6.5 and 7.0 was consistent
with these previously reported findings.
As shown in Supplementary Figure 6D, the DA-induced
dissolution of AFO is an important process as the relative residual
r is very sensitive to the change in the magnitude of the rate
constant. A slight increase in the shift point with increase in
pH is observed with this result in accord with the proposed rate
constants applied. However, compared with that of DA-induced
dissolution of AFO, the reductive dissolution after the adsorption
of DA onto the surface of AFO (Reaction 12, Table 2) is relatively
insensitive at both pH values used (Supplementary Figure 6E),
indicating that reductive dissolution is not as important as DA-
induced dissolution of AFO at each pH value investigated herein.
As shown in Supplementary Figures 6F,G, the formation of
both Fe[III]DA (Reaction 13, Table 2) and Fe[II]DA (Reaction
24, Table 3) are key reactions in this study as can be
seen from the relative sensitivities of the relative residuals
for these reactions. The rate constant for the formation of
the bis-complex from Fe[III]DA with another DA molecule
(Reaction 14, Table 2) is assumed to be similar to the rate
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TABLE 3 | Modeled reactions and rate constants for Fe[II]-catalyzed oxidation of DA at pH 6.5, 7.0 and 7.4.
No. reactions Rate constants (M−1s−1 or s−1) References
pH 6.5 pH 7.0 pH 7.4
21 Fe [II ] + O2
k21
−−→ Fe [III ] + O•−2 k21 = 0.0209 k21 = 0.0959 k21 = 0.77
b This study
22 Fe [II ] + O•−2
k22
−−→ Fe [III ] + H2O2 k22 = 1.0 × 10
7 10
23 Fe [II ] + H2O2
k23
−−→ Fe [III ] + •OH + OH– k23 = 1.72 × 10
3 k23 = 4.79 × 10






Fe[II]DA k24 = 7.0 × 10
2 k24 = 7.2 × 10
2 k24 = 7.5 × 10
2b This study
k−24 = 1.02 × 10
−2 k−24 = 9.2 × 10
−3 k−24 = 1.6 × 10
−3 This study
25 Fe [II ] DA + O2
k25
−−→ Fe [III ] DA + O•−2 k25 = 3.32 k25 = 19 k25 = 145
b This study
26 Fe [II ] DA + H2O2
k26
−−→ Fe [III ] DA + •OH + OH– k26 = 1.72 × 10
3 k26 = 4.79 × 10
3 k26 = 1.33 × 10
4 11
27 Fe [II ] DA + O•−2
k27
−−→ Fe [ III ] DA + H2O2 k27 = 1.0 × 10
7 8
28 Fe [II ] DA + DA•−
k28
−−→ Fe [III ] DA + DA k28 = 1.92 × 10
5b 5
29 Fe [II ] + DA•−
k29
−−→ Fe [III ] DA + DA k29 = 1.92 × 10
5b 5
aModified value of the model developed at pH 7.4 in Sun et al. (2016). brate constant taken from Sun et al. (2016). DA, dopamine; DA•−, dopamine semiquinone radical; O•−2 , superoxide;
Fe[III], inorganic ferric ion; Fe[II], inorganic ferrous ion; H2O2, hydrogen peroxide; and
•OH, hydroxyl radical. Refs: (11) González-Davila et al. (2005).
constant for water-loss from Fe(OH)(H2O)
2+
5 of 4.50 × 10
5
M−1s−1 (Blesa and Matijevi, 1989) in view of the fact that
the replacement of a coordinated H2O by the additional
DA molecule is generally faster than the formation of the
mono-complex (Ludwig et al., 1995). The results of sensitivity
analysis shown in Supplementary Figure 6H indicate that this
assigned value should be reasonable for the sensitivity of relative
residual r. Similar to the formation of the Fe-DA complexes,
dissociation of these complexes is also of great significance
given the considerable sensitivity of the rate constants over
several orders of magnitude (Supplementary Figures 6I–K). In
contrast to increase in the optimal value on decrease in pH
(Supplementary Figure 6I), the increase in the dissociation
rate constant shown in Supplementary Figure 6J is much less
significant. This supports the supposition that dissociation is
generally important at low pH with the bis-complex much
more stable in view of the iron sequestration. As shown in
Supplementary Figure 6L, relative insensitivity of the relative
residual r is evident for the deduced rate constant (3.7 × 105
M−1s−1) for the reaction between superoxide and AFO (Reaction
19, Table 2). As such, in order to simplify the model, the rate
constant of this reaction at high pH is considered to be the same
as that proposed previously (Sun et al., 2016). However, a value
for this rate constant of one order of magnitude lower is deduced
from model fitting in this study at pH 6.5 with this lower value
possibly a result of the increased proportion of HO•2 at this lower
pH and the subsequent reduced electrostatic attraction between
superoxide and the AFO surface.
Theoretically, change in pH would typically result in variation
of the Fe[II] oxidation rate in the presence of oxidants such
as DA•−. However, as shown in Supplementary Figure 6M,
considerable insensitivity of the relative residual is observed
around the value proposed at physiological pH. As such, a
consistent rate constant was used. Reduction of Fe[III] by DA•−
is important at pH 6.5 given the significant decrease in relative
residuals on variation of the rate constant (from 1 to 1010
M−1s−1; shown in Supplementary Figure 6N). Therefore, the
reaction between Fe[III] and DA•− is considered in the proposed
reaction scheme. The reduction of DA bound Fe[III] by DA•− is
not as significant as the reduction of Fe[III] in view of its lower
reduction potential. As such, reduction of organically complexed
Fe[III] by DA•− is not considered in the reaction scheme.
Dopamine-Derived Free Radical
Production Is pH Dependent
To assess how pH influences the generation of toxic DA
metabolites, the autoxidation of DA over a range of pH was
initially investigated with attention given to the accumulation of
H2O2 and DAC. As shown in Figure 1, spontaneous oxidation
of DA is highly pH-dependent with 20µM DA producing H2O2
at rates of 0.08, 0.12, and 0.24µM h−1 at pH 6.5, 7.0, and 7.4,
respectively. On the other hand, <0.1µM of DAC was produced
at pH 7.0 in the absence of Fe (Figure 2A).
The oxidation of DA by O2:
DA+O2 → DA
•− +O•−2 (6)
is often considered to be a critical step in the production of H2O2
and DAC. Firstly, DA•− can disproportionate to form DAQ
which subsequently cyclizes to DAL. DAC and H2O2 can then
be produced either through the redox exchange between DAQ
and DAL (Equation 7) or as a result of the direct oxidation of
DAL (Equation 8), O•−2 disproportionation (Equation 9) and/or
the O•−2 -mediated transformation of radicals such as DA
•−
(Equation 10; Hawley et al., 1967; Graham, 1978; Sun et al., 2016).
DAQ+ DAL → DA+ DAC (7)
DAL+O2 → DAC+H2O2 (8)
O•−2 +O
•−
2 → H2O2 +O2 (9)
O•−2 + DA
•− → DAQ+H2O2 (10)
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Among the various reactions shown above, the direct oxidation
of DA by O2 to DA•− and O
•−
2 (Equation 6) is expected to be
rate limiting in view of the spin restriction inherent between DA
and O2 and, accordingly, exhibits a small rate constant (Table 1).
With this in mind, any factors that influence this rate-limiting
step (such as the presence of Fe[II] and Fe[III]; see Section Iron
Accelerates Dopamine Oxidation) will alter the rate of formation
of products arising from the oxidation of DA.
In general, the apparent oxidation rate of DA is determined
by the contribution of different DA species. The pH-dependent
formation of H2O2 shown in Figure 1 is attributed, at least
partially, to the increase in the proportion of deprotonated DA
ions on increase in pH; i.e.,
kapp = αH2DAkH2DA+O2 + αHDAkHDA−+O2
+αDA2−kDA2−+O2 (11)
where kapp is the apparent oxidation rate constant, αi is the
fraction of total DA species present as species i and ki is the
intrinsic oxidation rate constant of species i. Previous work
has suggested that the abstraction of a hydrogen atom from
the mono-deprotonated form of DA is the rate limiting step in
the oxidation of DA (Herlinger et al., 1995). As such, it is not
unexpected that an increase in the proportion of deprotonated
DA on increase in pH would give rise to the enhanced generation
of both DA•− and O•−2 via Equation 6, eventually resulting in
the subsequent increase in the concentration of H2O2. Compared
with the significantly enhanced production of H2O2 in the
presence of iron (shown in section Iron Accelerates Dopamine
Oxidation), while continuously formed, the toxicity induced by
the autoxidation of DA is unlikely to be significant given the
presence of in vivo oxidant removal enzymes, such as superoxide
dismutase 1 (SOD1) and the glutathione peroxidases (GPx),
though there is evidence that both enzymes are dysfunctional in
Parkinson’s disease (Cardoso et al., 2017; Trist et al., 2017, 2018).
Additionally, the presence of DA-derived quinones is expected to
be negligible (as shown in Figure 2A).
Iron Accelerates Dopamine Oxidation
In order to quantify the rate of generation of ROS and reactive
quinones arising from the interaction between Fe and DA over
pHs ranging from those of the physiological neuronal cytosol
to those that have experienced disease-related and post-mortem
acidosis, the accumulation of DAC and the concentrations of
the key Fenton reagents–Fe[II] and H2O2-were subsequently
investigated.
In contrast to the negligible production of DAC in the absence
of Fe, a substantially higher concentration was generated in the
presence of 5µM iron at pH 7.0. In general, our results show
that Fe[II] was more effective in catalyzing DAC production than
was Fe[III] (Figure 2A). The initial rate of formation of DAC in
the presence of both Fe[II] and Fe[III] increased significantly at
pH 7.0 and 7.4 (Figures 2B,C). By contrast, the concentration
of DAC plateaued in the latter stages of the 120min assessment
period at pH 7.4, more so in the presence of Fe[II].
Accordingly, labile Fe also accelerated the production of
H2O2, again with Fe[II] being generally more efficient than
Fe[III], particularly during the initial∼10min following addition
of reagents (Figure 3A).While H2O2 was continuously produced
at pH 7.0 and 7.4 in the presence of both Fe species, at pH 6.5
only Fe[III] showed an increase in H2O2 production though the
concentration present at t = 120min was only ∼10% of that
produced at pH 7.4 (Figure 3B). For Fe[II], H2O2 concentration
remained stable after a subtle increase from t = 0–10min.
Accompanying the rapid generation of both DAC and H2O2
was a significant decrease in the concentration of Fe[II]. The
apparent oxidation rate of Fe[II] significantly increased in the
presence of DA. In the absence of DA, the concentration of
Fe[II] halved over 2 h at pH 7.0 (Supplementary Figure 7A)
while Fe[II] levels were near-totally depleted within 30min in the
presence of 10µMDA at the same pH (Figure 4A).





the oxidation of Fe[II] depends on the concentration of dissolved
O2 present. As the O2 concentration in brain tissue is typically
in the range of 10–60µM (Koppenol and Butler, 1985; Ndubuizu
and Lamanna, 2007), which corresponds to <5% O2 saturation
in aqueous solutions, the effect of O2 (at 2.5 and 5% saturation)
on the transformation of Fe[II] in the presence of DA was
examined at pH 7.0. As expected, both the rate and extent
of Fe[II] oxidation decreased with lower O2 concentration,
with only a 10% decrease in Fe[II] concentration at pH 7.0
in 5% O2 at t = 2 h compared with a 40% decrease at 21%
O2 saturation (Supplementary Figure 7B). Oxidation of Fe[II]
followed an exponential decay on addition of 10µM DA at pH
7.0 with initial Fe[II] exhausted after ∼70min in 21% O2 and
80–90% loss at 2 h for physiologically-relevant O2 concentrations
(Figure 4B). Accordingly, the initial formation of FeIIIDA2 was
strongly dependent on O2 concentration with markedly lower
rates observed at 2.5 and 5% O2 (Figure 4C).
Dopamine Induces Iron Mobilization
As predicted by thermodynamic and kinetic data, the majority
of Fe[III] should be present in an insoluble phase, even in the
presence of 20µM DA. As such, the continuous generation
of both DAC and H2O2 in the presence of Fe[III] shown in
Figures 2C, 3B suggests that DA is capable of inducing the
slow release of reactive soluble Fe species. Indeed, dissolution of
precipitated Fe by DA may pose a potential risk in view of its
contribution to the labile iron pool (Dixon and Stockwell, 2014)
and subsequent DA oxidation. Thus, to understand the extent
of DA-induced mobilization of Fe[III], the temporal change in
concentration of Fe[III]DA2 was measured over the pH range
of 6.5 to 7.4. To eliminate potential confounding effects of
O2-mediated transformation of both Fe and reducing radicals,
Fe[III]DA2 formation was investigated under anoxic conditions.
As shown in Figure 4D, Fe[III]DA2 formation increased gradually
at pH 7.0 and 7.4 in the presence of high initial DA concentration
(50µM) though not at pH 6.5. At this pH 6.5, Fe[III]DA2
formation was ∼60% of that produced at circumneutral pH;
a trend conserved at a lower DA concentration (20µM;
Supplementary Figure 5).
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Compared with pH 6.5, the increase in the overall
concentration of FeIIIDA2 at pH 7.0 and 7.4 can most likely
be attributed to: (i) the reduced rate of LMCT resulting from
the increased proportion of FeIIIDA2 present, and (ii) more
efficient formation of transient >Fe[III]-DA surface complexes
that precede thermal detachment of DA-bound Fe (Equation 13)
and/or DA-induced reductive dissolution (Equation 14):
>Fe[III]n + DA → >Fe[III]n−1 + Fe
[III]DA (13)
>Fe[III]n + DA → >Fe[III]n−1 + Fe[II]+ DA
•− (14)
Ex vivoModeling Predicts Potential Toxicity
of Iron-Mediated Dopamine Oxidation
The kinetic model developed in this study was used to infer
potential long-term effects of the combined mechanisms of DA
oxidation in the presence of Fe. Particular emphasis was given to
the effect of system conditions on Fe turnover rate (TOR; used
as a measure of Fe-specific catalysis) and associated hydroxyl
radical and DAC production, encompassing changing DA and
H2O2 concentrations and steady-state dissolvedO2. In this study,
given the overall goodness of the model fit to the experimental
data (Figures 1–5, Supplementary Figures 5, 7), the TOR was
determined from the oxidation rate of Fe[II] as predicted by the
model under particular conditions (e.g., pH, total concentration
of Fe, the concentration ratio of Fe to DA and O2 content).
Dopamine Concentration Mediates Iron Redox
Cycling
In general, cycling rate of Fe was highest during the
initial phase of each experiment and was amplified by
increasing concentration of DA (Figure 5A) and higher pH
(Supplementary Figure 9). After the initial dynamic cycling
period, the TOR steadily decreased and appeared to reach
equilibrium after ∼30min. Both acidic pH (pH 6.5) and DA
concentration dictated higher Fe TOR at the near-midpoint of
the reaction time (t = 50min); the presence of 30µM DA
induced a 10-fold increase in turnover rate compared to DA-
absent conditions at pH 6.5 whereas at pH 7.0 and 7.4 the increase
in TOR represented only 2 and 1.3-fold change, respectively
(Figure 5B). From this, we conclude that the effect of DA on
Fe TOR is much more substantial in acidic conditions with this
likely contributing to the abeyance of H2O2 generation (shown in
Figure 3A) and predicted increase in •OH production as a result
of both Fenton chemistry (Equations 1, 2) and Fe[II]-mediated
DA oxidation (Reactions 23 and 26, Table 3).
Kinetic Modeling of Sustained Parkinsonian
Oxidative Stress
As a result of the attenuation by endogenous antioxidants,
including SOD1, GPx, and endogenous ascorbate ions (Harrison
and May, 2009), in vivo steady-state concentrations of H2O2
stemming from normal mitochondrial respiration in the brain
are estimated to be maintained at around 5 nM (Adam-Vizi,
2005). However, concomitant hypoxia thought to occur in the
Parkinson’s disease brain (Adams and Odunze, 1991) may result
in both the accumulation of lactate as a result of the anaerobic
conditions, which, in turn, may contribute to the decrease in
FIGURE 5 | Predicted turnover rate (TOR) of 5µM Fe[II] in air-saturated (21%
O2) solutions with increasing DA concentrations at pH 7.0 (A) and at pH 6.5,
pH 7.0, and pH 7.4 after 50min (B).
pH, as well as a release of DA from chemically-isolated vesicles
(Phebus et al., 1986).
To predict the rate of •OH generation in a chemical
environment more reflective of continued replenishment of pro-
oxidants in a DA neuron, the kinetic model was applied where
pseudo-equilibrium was reached in the presence of a range of
fixed H2O2 and DA concentrations. While it must be emphasized
that this model is illustrative, as it is specific to only DA-
derived oxidative stress, it represents an important advance in
understanding the biochemical mechanism by which gradual
neuronal Fe accumulation with age can become pathological in
cells with both high metabolic output and an abundance of a
pro-oxidant catecholamine in DA.
As shown in Figure 6A, at a fixed concentration of 50µM
DA, increased •OHproduction rate was observed with increasing
H2O2 concentration and decreasing O2 concentrations over a
10–60µM range typical of that within the brain (Ndubuizu
and Lamanna, 2007). The increased production of hydroxyl
radicals as H2O2 becomes more concentrated can be attributed
to the relatively slow oxygenation rates at these conditions
and the potential for active peroxidation of any Fe[II]
present. In contrast, the effect of DA concentration on •OH
production as predicted by the model was more complex
(Figure 6B; Supplementary Figure 10) as DA can both sequester
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FIGURE 6 | Kinetic modeling of •OH production variability in the presence of 5µM Fe[II] as a function of both fixed concentrations of O2 and H2O2 and steady-state
50µM DA at pH 7.0 (A); and •OH (B) and DAC (C) production as a function of both fixed concentrations of H2O2 and DA at pH 6.5.
Fe[II] and Fe[III] in a variety of coordination complexes
and mobilize Fe[III] from ferric oxide precipitates via DA
induced dissolution. As a whole, DA concentrations under
0.1µM produce minimal amounts of •OH regardless of the
steady-state H2O2 concentration with this effect principally a
result of there being insufficient labile Fe present to promote
oxidation. In contrast, as DA concentrations exceed 10µM,
production of •OH is accelerated, provided the steady-state
H2O2 concentration is in excess of ∼100 nM, indicating that the
leakage of DA at the later stage may aggravate the Fe and DA
induced oxidative stress.
Again, the effect of increasing pH that promotes FeIIIDA2
complex formation partially attenuates •OH production
(Supplementary Figure 10), whereas FeIIIDA production
favored at pH 6.5 results in an increase in •OH generation rate
(Figure 6B; Supplementary Table 2) compared to the behavior
observed at both higher pH values and equivalent DA and H2O2
concentrations in an Fe-free environment.
Dopamine concentration had the largest effect on DAC
production for all pH values investigated (Figure 6C;
Supplementary Figure 11) with the highest rate of quinone
formation observed at pH 6.5. On the other hand, while the
model indicated H2O2 concentration had minimal influence
on the rate of DAC formation at pH 6.5, low concentrations of
H2O2 at pH 7.0 and pH 7.4 favor the accumulation of DAC,
particularly at the lower range of DA concentrations used.
Highlighting the versatility of Fe redox activity and why it is
tightly regulated under normal physiological conditions, these
results suggest that the oxidative load in a dopaminergic neuron
arising from Fe-mediated •OH production at basal H2O2 levels
are somewhat mitigated by the concomitant oxidation of Fe[II],
effectively sequestering Fe in the ferric state, which is less active
with respect to neurotoxic DAC production.
DISCUSSION
The value of this study is in the detailed kinetic and
thermodynamic profiling of DA oxidation, which provides direct
chemical evidence to support the involvement of this unique
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source of oxidative stress in a potentially pathogenic mechanism
of dopaminergic neurotoxicity.
Iron, Dopamine, and Selective Neuronal
Loss in Parkinson’s Disease
Iron accumulates in multiple regions of the aging human brain
(Acosta-Cabronero et al., 2016), and is most marked in the Fe-
rich deep gray matter within the basal ganglia (Li et al., 2014).
The degree of accumulation in Parkinson’s disease patients is
markedly higher in the SNc and putamen (Wang et al., 2016),
where dopaminergic neurons project, and is associated with
disease severity (Wallis et al., 2008), suggesting elevated levels
of Fe are intrinsically linked to the biochemical mechanism
underlying neuron loss (Hare et al., 2015). The disease-
specific hyperaccumulation of Fe throughout the nigrostriatal
pathway (He et al., 2015) indicates a particular vulnerability
of dopaminergic neurons, and a lack of apparent pathology
in non-Parkinson’s-affected regions that also accumulate Fe
during normal aging (Acosta-Cabronero et al., 2016) support
the hypothesis that DA oxidation and free radical generation,
occurring either independently of, or concurrent to, classical
Fenton chemistry is a major source of oxidative stress in
Parkinson’s disease.
This characteristic feature may explain how two essential
neurochemicals, which are normally segregated by vesicular
confinement of DA to prevent oxidation by cytoplasmic Fe,
are able to interact in the Parkinson’s disease brain, and
how they relate to α-synuclein dysfunction. Both mutations
to the SNCA gene encoding α-synuclein and post-translational
oxidative damage to the protein (Lotharius and Brundin, 2002b),
the latter being an effect of elevated levels of Fe and Fenton-
type ROS production, can lead to permeabilized vesicles that
effectively “leak” DA into the pro-oxidant environment of the
cytoplasm (Lotharius and Brundin, 2002a). This initial •OH-
driven oxidative damage may trigger a cascade of free radical
production that accelerates the rate of α-synuclein modifications,
impaired vesicular transport, and DA oxidation, in turn,
aggravating cell loss by triggering DAC-induced neurotoxicity.
Central to the view that elevated Fe facilitates DA breakdown
is the notion of a labile Fe pool. The propensity of unbound
cytoplasmic Fe[II] to react with by-products (such as H2O2) of
mitochondrial respiration necessitates tight metabolic regulation
of neuronal Fe levels involving various regulatory proteins (Moos
et al., 2007), a number of which have been recognized as being
dysfunctional in Parkinson’s disease (Hare et al., 2013). Whether
a labile Fe pool exists in actuality is the subject of much debate
and both rapid oxidation of Fe[II] in the O2-rich environment
and obvious difficulties in directly speciating Fe within a living
human neuron represent two analytical challenges that preclude
obtaining conclusive evidence that Fe dyshomeostasis actively
promotes increased oxidative stress in Parkinson’s disease.
Regardless, as nigral Fe accumulation is now recognized as an
indisputable pathological feature of Parkinson’s disease (Ayton
and Lei, 2014; Wang et al., 2016), understanding the mechanism
of how Fe promotes oxidative stress in dopaminergic neurons is
critical as Fe chelation therapies enter clinical trials (Devos et al.,
2014; Martin-Bastida et al., 2017; Moreau et al., 2018; Sun et al.,
2018c).
Iron-Induced Dopamine Radical
Production Is Independent of Fenton
Chemistry
Iron-mediated DA oxidation differs from Fenton/Haber-Weiss
chemistry in that, in addition to redox cycling of Fe[II]/Fe[III],
both species are capable of forming intermediary complexes
immediately preceding free radical production. For instance,
both Fe[II] and Fe[III] are capable of d orbital “bridging” between
DA and O2, and inducing the subsequent accelerated transfer of
electrons and generation of DA•− and O•−2 free radicals (Miller
et al., 1990). The reactions and associated rate constants involved
in Fe[II]/Fe[III] redox cycling and DA oxidation are listed in
Tables 2, 3.
The particularly strong ability of Fe[II] to generate DAC
and H2O2 evident in Figures 2, 3 may result from the relative
insolubility and precipitation of Fe[III] as AFO over the pH
range investigated. This is an important factor to consider, as
ferritin sequesters Fe within a protein nanocage in a chemical
state resembling AFO (Jian et al., 2016). However, the ready
oxidation of Fe[II] in the presence of DA (Reaction 24 and
Reaction 25 in Table 3) favors the conversion of Fe[II] to the
Fe[III]DA complex and subsequent O•−2 generation (Sun et al.,
2016). Fe[III]DA is not particularly stable and may either react
with another DAmolecule to form FeIIIDA2 (shown in Figure 4C
and Supplementary Figure 7C), reversibly react with O•−2 to
reform Fe[II]DA and O2 or undergo ligand-to-metal charge
transfer (LMCT) with release of Fe[II] and DA•− as follows:
Fe[III]DA → Fe[II]+ DA•− (15)
Compared to the relatively inactive iron oxyhydroxide
precipitates, the more soluble DA-bound Fe[III] oxidation
product formed from ferrous DA complexes should enhance the
production of both DAC and H2O2 by accelerating generation of
both DA•− and O•−2 radicals.
Distinguishing iron-mediated dopamine oxidation from
Fenton-generated ROS is important, as the free radicals produced
do not have the multiple redundant detoxification pathways
that exist for H2O2. While quinones are a relatively minor
component of dopamine metabolism, which ordinarily favors
providing a precursor for adrenaline biosynthesis or excretion
from the central nervous system as homovanillic acid, it is unclear
precisely how these highly-reactive species are neutralized.
Several endogenous enzymes have been shown to interact with
dopamine o-quinones, including SOD1, glutathione transferase
(by way of glutathione conjugation) and macrophage migration
inhibitory factor (Solano et al., 1999; Haque et al., 2003),
though quinone detoxification would be considered a secondary
function. In the absence of metal catalysis, polymerization of
quinones to neuromelanin is a remarkably slow process with a
normal aged brain containing only around 5mg g−1 (Aime et al.,
2000).Without an efficient mechanism of quinone removal, these
products have greater neurotoxic potential. This is especially the
case in human dopaminergic neurons, in light of recent data
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indicating that dopaminergic neurons derived from fibroblasts of
sporadic and familial Parkinson’s disease patients contain higher
concentrations of DA and oxidation products than similarly-
prepared murine cell cultures (Burbulla et al., 2017).
Relevance of Iron and pH to Disease
Progression
The rapid formation of both DAC and H2O2 may be attributed
to the pH-dependent oxidation of DA-bound Fe[II] shown
in Figure 4A. Variation in pH reflecting transition from a
physiologically normal microchemical environment to Parkin-
associated mitochondrial dysfunction (Pickrell and Youle, 2015)
and post-mortem acidosis (Donaldson and Lamont, 2013) had
a marked effect on DAC and H2O2 production concomitant to
pH-dependent oxidation of Fe[II]. The catechol moiety of DA is
capable of forming a strong complex with Fe[III] (Avdeef et al.,
1978; Sever and Wilker, 2004):
Fe[III]+ DA → Fe[III]DA (16)
with the mono-complex (Fe[III]DA) dominant at acidic pH
and the bis Fe[III]DA2 complex favored at circumneutral
pH (Supplemental Figure 4). At pH 6.5, the ratio of
[Fe[III]DA2]/[Fe[III]DA] is ∼5 in conditions reflective of
otherwise physiologically normal concentrations of Fe and DA.
Once formed, radical generation would also occur, increasing
potential protein and lipid peroxidation events with the rate of
LMCT for Fe[III]DA (0.23 s−1) substantially higher than that for
Fe[III]DA2 (7.26 × 10−5 s−1; El-Avaan et al., 1997; Sun et al.,







continuous generation of DAC at pH 6.5, especially in the
presence of Fe[II], was unsurprising. The slightly higher
concentrations of DAC formed in the presence of Fe[III],
particularly during the initial half of the total reaction time
assessed (Figure 2C), may be attributed to the more efficient Fe
mobilization induced by DA at higher pH.
In contrast to the slower yet continuous generation of H2O2 at
pH 7.0 and 7.4 (Figure 3A), the non-linear formation of DAC at
these pHs (Figure 2B) suggests that DAC levels are maintained
at a steady-state under physiological conditions through
rearrangement of DAC and the subsequent formation of indoles
or even possibly neuromelanin (Supplementary Figure 8). It is
reasonable to deduce that the rearrangement of DAC coupled
with the ensuing polymerization on increase in pH plays an
important role in the removal of DAC.
It should be noted that the presence of metals, such as Fe
and calcium (as Ca2+) can also promote this process (Sun
et al., 2018a). The model developed adequately describes the
generation of reactive oxygen species and accumulation of DAC
but comprehensive description of the specific role of Fe in DAC
decomposition will require an expanded model. Regardless, the
accumulation of protein-modifying DAC is likely to be enhanced
at low pHs as a result of the presence of high concentrations of
the active Fe[II] catalyst seen in both parkinsonian animalmodels
(Hare et al., 2014; Billings et al., 2016) and the human Parkinson’s
disease brain (Dexter et al., 1991).
The cessation of H2O2 accumulation observed at pH 6.5
(Figure 3A) may be related to the high concentration of Fe[II]
present in the solution. Under these conditions, the H2O2
initially generated as a result of DA-enhanced oxidation of Fe[II]
is subsequently consumed via peroxidation of the remaining
Fe[II]. Apart from the obvious pH-dependent oxidation process,
attenuation of Fe[II] oxidation at pH 6.5 (Figure 4A), especially
during the later stages of the reaction, suggests that Fe[II] may
be regenerated under these conditions with the regeneration of
Fe[II] related to formation of DA intermediates such as DA•−.
Given the continuous generation of DAC (Figure 2B), the high
concentrations of Fe[II] observed may, in turn, result from
DA•−-induced reduction of ferric iron. Thermodynamically, the
low reduction potential of the DAQ/DA•− couple indicates that
reduction of aqueous Fe[III] is feasible (Pham and Waite, 2014).
Indeed, the rapid reduction of Fe[III] by 6-hydroxydopamine (6-
OHDA) semiquinones has been proposed (Jameson and Linert,
2001) with 6-OHDA itself a neurotoxic breakdown product of
DA that is facilitated by Fe (Hare and Double, 2016). However,
as pH increases, it is expected that the majority of the Fe
present would be efficiently converted into AFO and, with a low
reduction potential at pH 7.0 (Watt et al., 1985), DA•− is unable
to mobilize Fe from AFO. It is of note that neuronal ferritin iron
is stored in an AFO-like ferrihydrite core (Hagen et al., 2017)
which is prone to mobilization under acidic conditions (La et al.,
2017).
Considerations for Analysis of Dopamine
Metabolites in Post-mortem Tissue
When viewed within the context of existing literature, the results
described here present something of a conundrum for those
wishing to quantify DAC and related DA oxidation products
in human SNc tissue. While acidosis occurring in degenerating
neurons may contribute to the progression of Parkinson’s disease
by increasing the rate of oxidant generation and accumulation
of DAC, post-mortem decreases in tissue pH, stemming from
sample handling, exposure to the environment after removal at
autopsy, and even post-mortem interval may present inaccurate
assessment of DA oxidation.
Considering mitochondrial dysfunction is common to most
neurodegenerative diseases (Lin and Beal, 2006), it is not
surprising that data supplied from tissue housed in the Sydney
Brain Bank, where 72% of cases with a neurodegenerative
disease, including pathologically-diagnosed Parkinson’s disease,
exhibited tissue pH as low as 5.86 (Genoud et al., 2017). Tissue
pH that deviates from normal physiology, regardless of whether
the cause is endogenous or artifact, will undoubtedly alter the
speciation of DA and Fe, and rate of formation, reactivity and
fate of toxic DA intermediates (El-Avaan et al., 1997; Pham
et al., 2006; Sun et al., 2015, 2016, 2018a). Accordingly, to avoid
anymisinterpretation of DAmetabolites, quantitative assessment
of DA metabolism in post-mortem tissue should account for
multiple confounding factors that influence tissue pH.
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FIGURE 7 | Schematic showing the relative importance of the various reactions involved in the interplay between DA and Fe. Expected changes in key metabolites on
decrease in pH are also shown.
CONCLUSIONS
The results of this study indicate that the formation of DA
bound Fe[II] and Fe[III] complexes as well as the cyclization
and rearrangement of DA-derived quinones are the most
important pathways of DA metabolism, with each process
heavily dependent on pH. A schematic showing the relative
importance of these processes together with expected changes
in key metabolites on decrease in pH is presented in Figure 7.
The presence of Fe can accelerate the oxidation of DA and the
accumulation of deleterious protein-modifying DAC with Fe[II]
being more efficient in this regard than Fe[III]. Although DAC
was slowly formed at pH 6.5, the decrease in the rearrangement
rate of this species in acidic conditions resulted in long-term
accumulation of DAC. As a result of both the rapid reduction
of the unbound-Fe[III] by DA•− and the enhanced LMCT that
occurs with the change in the speciation of DA-bound Fe, a
substantially higher concentration of Fe[II] was generated at pH
6.5 compared to that at pH 7.0 and 7.4. Even though the presence
of both Fe[III] and Fe[II] resulted in increased accumulation of
H2O2, the enhanced Fe[II] regeneration coupled with the slow
rate of oxygenation of Fe[II] at pH 6.5 gave rise to substantially
greater potential for the peroxidation of Fe[II] with concomitant
enhanced generation of •OH. Model predictions indicate that,
in the presence of the same concentrations of DA and H2O2,
acidosis in the Parkinson’s disease brain results in an increase
in DAC accumulation and DA-mediated production of hydroxyl
radicals, with these potential toxicants likely to further aggravate
the progression of Parkinson’s disease and severity of symptoms
arising from DA denervation.
The model developed in this study places emphasis on
the purely chemical interactions between Fe and DA and is
of particular value in facilitating prediction of the long-term
consequences of these interactions by incorporating a range of
conditions resulting from the complicated in vivo homeostasis
of dopaminergic neurons such as continuous DA leakage into
the cytosol and increased steady-state concentrations of H2O2 as
a result of the dysfunctional of antioxidant enzymes. It is also
important to view these data within the broader biochemical
context of Parkinson’s disease neuropathology as a result of the
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limitations of current techniques. Regardless, the data presented
here shows that pH, Fe and H2O2 concentrations are intrinsically
linked in the rate of formation of neurotoxic DA metabolites.
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